Delatestryl®: TRT Reduces Gout Risk in Hypogonadal American Males
Reading Time: 2 minutes Introduction Gout, a debilitating form of inflammatory arthritis, affects over 9 million Americans, with a disproportionate burden on males—particularly those aged 40 and older. Characterized by hyperuricemia leading to monosodium urate crystal deposition in joints, gout manifests as acute, excruciating pain, often in the big toe (podagra). In the United States, where obesity rates exceed 42% among adult males and dietary purine intake is high from processed meats and sugary beverages, gout incidence has surged 30% in the past two decades per CDC data. Emerging evidence implicates late-onset hypogonadism—a prevalent condition in 20-30% of American men over 50—as a modifiable...


